ERX-41

N/A

Report date: 2023/09/05 14:01:41
NME

Base Information

Drug NameERX-41
Drug Alias NameERX-41
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLysosomal acid lipase/cholesteryl ester hydrolase inhibitors
TargetsLysosomal acid lipase/cholesteryl ester hydrolase
Therapy Area/IndicationsTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity of Texas Southwestern Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of Texas Southwestern Medical CenterEtirarx LLC
Inactive CompaniesN/A
Active IndicationsTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A